Skip to content

A study of prescriptions to analyse the treatment being given to patients suffering from ring worm infection

Prescription audit of anti-fungal treatment of dermatophytoses in the Dermatology out patient department of a tertiary care hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/03/012838
Enrollment
370
Registered
2018-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue Health Condition 2: null- patients diagnosed with dermatophytoses in the opd

Interventions

None listed

Sponsors

Diamond Jubilee society trust
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients aged 12 to 65 years 2 Either genders 3 Newly diagnosed patients 4 Follow-up patients already on anti fungal therapy 5 Patients willing to give written informed consent and assent

Exclusion criteria

Exclusion criteria: 1 patients diagnosed with tinea unguium tinea capitis or Majocchi granuloma 2 Any other concomitant skin diseases such as psoriasis eczema etcetra 3 Other systemic illnesses being treated with drugs such as rifampicin phenytoin etcetra which may result in drug interactions

Design outcomes

Primary

MeasureTime frame
To study the prescriptions of clinically diagnosed cases of dermatophytosesTimepoint: 4 to 8 weeks

Secondary

MeasureTime frame
To evaluate treatment of clinical failure cases To estimate rise in serum ALT levels To evaluate availability of drugs in hospital pharmacy Cost minimization analysis of oral antifungal drugs prescribed Timepoint: 4 to 8 weeks

Countries

India

Contacts

Public ContactYashashri C Shetty

Seth G S Medical College and K E M Hospital

yashashrirajit@gmail.com9869193041

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026